Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1
The NM_012222.3(MUTYH):c.158-1_159delGGGinsCGT(p.54) variant causes a splice acceptor, splice region, synonymous, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type MNV, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. G53G) has been classified as Likely benign.
MUTYH (HGNC:7527): (mutY DNA glycosylase) This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017]
MUTYH Gene-Disease associations (from GenCC):
familial adenomatous polyposis 2
Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, G2P, Orphanet
colorectal cancer
Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
familial ovarian cancer
Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
hereditary breast carcinoma
Inheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 3.2, offset of -23, new splice context is: acaggctgctgtgtcccaAGacc. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_012222.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Sel.
Gene
Transcript
Tags
HGVSc
HGVSp
Effect
Exon Rank
Protein
UniProt
MUTYH
NM_001128425.2
MANE Plus Clinical
c.166_168delGGGinsCGT
p.Gly56Arg
missense
N/A
NP_001121897.1
E5KP25
MUTYH
NM_001048174.2
MANE Select
c.116-34_116-32delGGGinsCGT
intron
N/A
NP_001041639.1
Q9UIF7-6
MUTYH
NM_001407083.1
c.124_126delGGGinsCGT
p.Gly42Arg
missense
N/A
NP_001394012.1
E9PM53
Ensembl Transcripts
Sel.
Gene
Transcript
Tags
HGVSc
HGVSp
Effect
Exon Rank
Protein
UniProt
MUTYH
ENST00000710952.2
MANE Plus Clinical
c.166_168delGGGinsCGT
p.Gly56Arg
missense
N/A
ENSP00000518552.2
E5KP25
MUTYH
ENST00000456914.7
TSL:1 MANE Select
c.116-34_116-32delGGGinsCGT
intron
N/A
ENSP00000407590.2
Q9UIF7-6
MUTYH
ENST00000372098.7
TSL:1
c.158-1_159delGGGinsCGT
p.54
splice_acceptor splice_region synonymous intron
N/A
ENSP00000361170.3
Q9UIF7-1
Frequencies
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.